Individualized precision medicine is an important national goal. While advancements in genomics have found traction in some clinical areas, such as oncology, work is being done to better understand its potential role in psychiatry. Researchers, including Dr. Frye, are making progress in understanding the genetic architecture of many psychiatric conditions, such as schizophrenia and bipolar disorder. These developments will impact the way mental healthcare providers go about diagnosing and treating their patients in the future, so it is important to stay up to date on developments in genomic understanding.
Professor and Chair, Department of Psychiatry and Psychology, Stephen and Shelly Jackson Family Professorship in Individualized Medicine; Director, Mayo Clinic Depression Center, Mayo Clinic
Sunday February 25, 2018 8:30am - 9:15am CST
JW Marriott Austin110 E. 2nd Street, Austin, TX 78701
